艾比森(300389.SZ):成功落地多個裸眼3D標杆項目
格隆匯7月20日丨有投資者向艾比森(300389.SZ)提問,“公司在裸眼3D方面有什麼發展成果和未來規劃?”
艾比森回覆稱,作為全球領先的至真LED顯示應用與服務提供商,成功落地多個裸眼3D標杆項目,公司於2023年被認定為“廣東省裸眼3D LED顯示工程技術研究中心”。主要應用案例有長沙春天百貨、成都蘭博基尼中心、濟南高新萬達廣場、上海虹橋樞紐奧所未來城等。隨着裸眼3D的普及與革新,艾比森也將不斷創新,拓展裸眼3D應用場景。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.